SYNDROMIC MULTIPLEX DIAGNOSTIC MARKETS
" SYNDROMIC MULTIPLEX PANELS MARKETS with COVID-19 IMPACTS. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Country. With Market Analysis, Executive Guides and Customization. 2022 to 2026 "
516 Pages packed with information
The Syndromic Diagnostics Market enters a new post pandemic growth phase as new entrants jockey for position in a New Diagnostic World.
How will COVID-19 affect Syndromic and Infectious Disease Diagnostics? The COVID pandemic is ushering in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician’s Office or even the Home?
Syndromic testing is proving itself in the market. Players are reporting double digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size out to 2025. In a special section the report looks at the numbers on how syndromic molecular diagnostics are replacing traditional panel based ordering of infectious disease tests.
Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.
See the Table of Contents.
Send an email to us at firstname.lastname@example.org and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part. And we will not pester you with phone calls!
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research and the American Association for Clinical Chemistry.
He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research - Burke Institute
Finance for Senior Executives - Harvard Business School